XORTX Therapeutics, Inc. is a biopharmaceutical company based in Calgary, Canada, focusing on developing innovative therapies for rare diseases like polycystic kidney disease and conditions related to high serum uric acid levels. Founded in 2011 by Allen Davidoff.